Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Swiss stocks - Factors to watch on October 13

Published 13/10/2020, 03:44 pm
Updated 13/10/2020, 05:12 pm
© Reuters.

© Reuters.

ZURICH/BERLIN, Oct 13 (Reuters) - The Swiss blue-chip SMI .SSMI was seen opening 0.4% higher at 10,408 points on Tuesday, according to premarket indications from bank Julius Baer JBPRE01 .

Here are some of the main factors that may affect Swiss stocks

ROCHE ROG.S

The Swiss drugmaker plans to start selling a higher-volume COVID-19 antigen test for laboratories by the end of the year as the company expands diagnostics for the pandemic. NESN.S

Aimmune Therapeutics Inc AIMT.O shareholders have backed Nestle's $2 billion offer to gain full ownership of the first U.S.-approved peanut allergy treatment, which has struggled with a slow launch due to the COVID-19 pandemic. THERAPEUTICS RLFB.S

The Swiss company said on Tuesday that more people who received a 50-year-old drug that it is seeking to re-purpose against COVID-19 were alive beyond 60 days than were those who did not get the medicine. It is still awaiting data from randomized trials. ADEN.S

Australia's cloud-based services provider Nvoi NVO.AX on Tuesday said it had agreed a new framework agreement with Zurich-based human resource services provider Adecco Group for the provision of recruitment website management and support services. STATEMENTS

* ACHIKO AG ACHIN.S established a medtech expert advisory board and expanded its management team. Flughafen Zuerich FHZN.S reported an 81.4% drop in passenger number in September compared to the previous year. Basilea Pharmaceutica BSLN.S said it completed an early phase study of a prospective drug against urothelial cancer. BSLN.S

* Peach Property Group PEAN.S says it plans a capital increase with mandatory convertible bond with a target volume of 200 million Swiss francs, with Klaus Schmitz to be a new anchor shareholder with about 30% of the company. PEAN.S

ANALYSTS' VIEWS

* SGS SA SGSN.S : JP MORGAN SETS SEP-21 PRICE TARGET OF CHF 2,600 VS JUN-21 PRICE TARGET OF CHF 2,500

* EMMI AG EMMN.S : CREDIT SUISSE CUTS TO NEUTRAL FROM OUTPERFORM, CUTS TARGET PRICE TO CHF 920 FROM CHF 940

* GEBERIT AG GEBN.S : MORGAN STANLEY RAISES TARGET PRICE TO CHF 477 FROM CHF 464

ECONOMY

No major economic data scheduled.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.